66666 Federal Register / Vol. 62, No. 244 / Friday, December 19, 1997 / Notices

By order of the Commission.

Donna R. Koehnke,

Secretary.

[FR Doc. 97–33210 Filed 12–18–97; 8:45 am]

BILLING CODE 7020–02–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated June 23, 1997, and

published in the Federal Register on

July 10, 1997 (62 FR 37077), Applied

Science Labs, Division of Alltech

Associates, Inc., 2701 Carolean

Industrial Drive, P.O. Box 440, State

College, Pennsylvania 16801, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Methcathinone (1237) ....................... I

N-Ethylamphetamine (1475) ............. I

N,N-Dimethylamphetamine (1480) .... I

4-Methylaminorex (cis isomer) (1590) I

Lysergic acid diethylamide (7315) .... I

Mescaline (7381) ............................... I

3,4-Methylenedioxyamphetamine

(7400) ............................................. I

N-Hydroxy-3,4-methylenedioxy- amphetamine (7402) ........................... I

3,4-Methylenedioxy-Nethylamphetamine (7404) .............. I

3,4-Methylenedioxymethamphetamine (7405) .................................... I

N-Ethyl-1-phenylcyclohexylamine

(7455) ............................................. I

1-(1-Phenylcyclohexyl) pyrrolidine

(7458) ............................................. I

1-[1-(2-Thienyl) cyclohexyl]piperidine

(7470) ............................................. I

Dihydromorphine (9145) .................... I

1-Phenylcyclohexylamine (7460) ...... II

Phencyclidine (7471) ......................... II

Phenylacetone (8501) ....................... II

1-Piperidinocyclohexanecarbonitrile

(8603) ............................................. II

Cocaine (9041) .................................. II

Codeine (9050) .................................. II

Dihydrocodeine (9120) ...................... II

Benzoylecgonine (9180) .................... II

Morphine (9300) ................................ II

Oxymorphone (9652) ........................ II

Noroxymorphone (9668) ................... II

The firm plans to manufacture small

quantities of the listed controlled

substances for reference standards.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Applied Science Labs to

manufacture the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to 21 U.S.C. 823 and 28 CFR 0.100 and

0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: November 28, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–33113 Filed 12–18–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.33(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on August 25, 1997,

Cambridge Isotope Lab, 50 Frontage

Road, Andover, Massachusetts 01810,

made application by renewal, which

was received for processing on

November 4, 1997, to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Methaqualone (2565) ........................ I

Dimethyltryptamine (7435) ................ I

Amphetamine (1100) ......................... II

Methamphetamine (1105) ................. II

Pentobarbital (2270) .......................... II

Secobarbital (2315) ........................... II

Phencyclidine (7471) ......................... II

Phenylacetone (8501) ....................... II

Cocaine (9041) .................................. II

Codeine (9050) .................................. II

Oxycodone (9143) ............................. II

Hydromorphone (9150) ..................... II

Benzoylecgonine (9180) .................... II

Methadone (9250) ............................. II

Dextropropoxyphene, bulk (non-dosage forms) (9273) .......................... II

Morhone (9300) ................................. II

Fentanyl (9801) ................................. II

The firm plans to manufacture small

quantities of the above listed controlled

substances for isotope labeled standards

for drug analysis.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than February

17, 1998.

Dated: November 28, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–33115 Filed 12–18–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated June 9, 1997, and

published in Federal Register on June

17, 1997, (62 FR 32824), Damocles10,

3529 Lincoln Highway, Thorndale,

Pennsylvania 19372, made application

by renewal to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Heroin (9200) .................................... I

Codeine (9050) .................................. II

Hydromorphone (9150) ..................... II

Hydrocodone (9193) .......................... II

Morphine (9300) ................................ II

The firm plans to manufacture the

listed controlled substances for the

purpose of deuterium labeled internal

standards for distribution to analytical

laboratories.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Damocles10 to

manufacture the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to 21 U.S.C. 823 CFR 0.100 and 0.104,

the Deputy Assistant Administrator,

Office of Diversion Control, hereby

orders that the application submitted by

the above firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

Dated: December 1, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–33116 Filed 12–18–97; 8:45 am]

BILLING CODE 4410–09–M